Italy: Sibylla Biotech, a company developing an innovative avenue for drug discovery by enabling the targeting of proteins while they are still folding, has closed a €23m (US$22.3m) Series A financing round led by V-Bio Ventures. It was joined by an international syndicate of specialized life sciences investors, with participation from Seroba Life Sciences, 3B…
Home Healthcare Markets International Business Financing round-up: Scailyte, Lifestores Healthcare, Remedial Health, Cowtribe, Sibylla Biotech